Showing results (371-380 of 572) with videos related to

Sort By:
Pageof 58
Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome TrialsMegumi Oshima, Luke Buizen, Niels Jongs, et al.
Journal of the American Heart Association|January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE TrialAbhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
JAMA Network Open|December 28, 2021
Assessment of an Interactive Digital Health-Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases: A Randomized Clinical TrialScott A Lear, Monica Norena, Davina Banner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2020
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trialsSimon D Roger, Bruce S Spinowitz, Edgar V Lerma, et al.
BMC Nephrology|January 19, 2017
Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trialIain C Macdougall, Andreas H Bock, Fernando Carrera, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2018
Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking SolutionBrenda R Hemmelgarn, Braden J Manns, Steven D Soroka, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical GuidanceMai Mohsen, Tae Won Yi, Labib Faruque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2014
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemiaIain C Macdougall, Andreas H Bock, Fernando Carrera, et al.
Pageof 58